Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.

Chondroitin 6-sulphate is required for neuroplasticity and memory in ageing

Open access

Abstract

Perineuronal nets (PNNs) are chondroitin sulphate proteoglycan-containing structures on the neuronal surface that have been implicated in the control of neuroplasticity and memory. Age-related reduction of chondroitin 6-sulphates (C6S) leads to PNNs becoming more inhibitory. Here, we investigated whether manipulation of the chondroitin sulphate (CS) composition of the PNNs could restore neuroplasticity and alleviate memory deficits in aged mice. We first confirmed that aged mice (20-months) showed memory and plasticity deficits. They were able to retain or regain their cognitive ability when CSs were digested or PNNs were attenuated. We then explored the role of C6S in memory and neuroplasticity. Transgenic deletion of chondroitin 6-sulfotransferase (chst3) led to a reduction of permissive C6S, simulating aged brains. These animals showed very early memory loss at 11 weeks old. Importantly, restoring C6S levels in aged animals rescued the memory deficits and restored cortical long-term potentiation, suggesting a strategy to improve age-related memory impairment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41380-021-01208-9

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Figures

Image 1
CC-BY · From the PDF
Image 2
CC-BY · From the PDF
Image 3
CC-BY · From the PDF
Fig. 2 Chondroitinase ABC treatment restores memory and Parvalbumin levels. A Timeline of ChABC treatment to young and aged mice. B ChABC injection rescued age-related OR memory de fi cit. 6 h memory at 20 M, unpaired two-tailed t -test, *** p = 0.0001. Twenty-four hours memory at 6M, unpaired two-tailed t -test, ** p = 0.0074. Wash-out of ChABC treatment effect of 6 h memory in 20 M mice. 2-Way ANOVA interaction treatment × time, *** p <0.001. Main effect of Time: ** p <0.01. Treatment: ** p <0.01. Bonferroni posthoc test, ChABC 2 weeks vs 6 weeks, *** p <0.001. Two weeks Pnase vs ChABC, *** p = 0.0002. C PV network in aged mice. 6 M vs 20 M low PV: ** p = 0.0012, high PV ** p = 0.0061, n = 6/group. Data present as mean ± SEM. D PV network modi fi cation after ChABC treatment in 6 M vs 20 M old mice 6 M Pnase vs ChABC n = 6/group, low: *** p <0.0001 medium: ** p = 0.0027 high: ** p = 0.0028, 20 M Pnase vs ChABC n = 4/group, low: * p = 0.019 High: ** p = 0.0099. E Representative images of the staining pro fi les of WFA (green), PV (magenta) and DAPI (blue) in 20 M old mice after Pnase and ChABC treatment. Scale bar: 50 µm.
Fig. 2 Chondroitinase ABC treatment restores memory and Parvalbumin levels. A Timeline of ChABC treatment to young and aged mice. B ChABC injection rescued age-related OR memory de fi cit. 6 h memory at 20 M, unpaired two-tailed t -test, *** p = 0.0001. Twenty-four hours memory at 6M, unpaired two-tailed t -test, ** p = 0.0074. Wash-out of ChABC treatment effect of 6 h memory in 20 M mice. 2-Way ANOVA interaction treatment × time, *** p <0.001. Main effect of Time: ** p <0.01. Treatment: ** p <0.01. Bonferroni posthoc test, ChABC 2 weeks vs 6 weeks, *** p <0.001. Two weeks Pnase vs ChABC, *** p = 0.0002. C PV network in aged mice. 6 M vs 20 M low PV: ** p = 0.0012, high PV ** p = 0.0061, n = 6/group. Data present as mean ± SEM. D PV network modi fi cation after ChABC treatment in 6 M vs 20 M old mice 6 M Pnase vs ChABC n = 6/group, low: *** p <0.0001 medium: ** p = 0.0027 high: ** p = 0.0028, 20 M Pnase vs ChABC n = 4/group, low: * p = 0.019 High: ** p = 0.0099. E Representative images of the staining pro fi les of WFA (green), PV (magenta) and DAPI (blue) in 20 M old mice after Pnase and ChABC treatment. Scale bar: 50 µm.CC-BY · From the PDF
Image 5
CC-BY · From the PDF
Image 6
CC-BY · From the PDF
Image 7
CC-BY · From the PDF
Image 8
CC-BY · From the PDF
Image 9
CC-BY · From the PDF
Fig. 3 Aged mice lose C6S. Knockout of C6 sulfotransferase levels lead to premature memory loss. A Increase in the ratio of C4S/C6S in aged mice suggests a depletion of C6S. Left, general interstitial matrix. Right, PNN matrix. B OR memory loss (3 h) in chst3 knockout mice. Unpaired two-tailed t -test. 11 weeks: * p = 0.0317. 13 weeks: * p = 0.0306. 18 weeks: * p = 0.0165. C Impaired spontaneous alternation performance in chst3 knockout mice. Unpaired two-tailed t -test, 4 M: ** p = 0.0011. 7 M: ** p = 0.001. D Atypical marble-burying behaviour in chst3 KO mice on ageing. Unpaired two-tailed t -test. 12 M: ** p < 0.01. In WT the ageing impaired marble-burying behaviour, 7 M vs 12 M *** p < 0.001. E Experimental timeline of AAVchst3 injection to chst3 KO mice at 4 M. F chst3 gene delivery recovered memory in 4 M chst3 KO mice line. Unpaired two-tailed t -test, 3 h delay: ** p < 0.01.
Fig. 3 Aged mice lose C6S. Knockout of C6 sulfotransferase levels lead to premature memory loss. A Increase in the ratio of C4S/C6S in aged mice suggests a depletion of C6S. Left, general interstitial matrix. Right, PNN matrix. B OR memory loss (3 h) in chst3 knockout mice. Unpaired two-tailed t -test. 11 weeks: * p = 0.0317. 13 weeks: * p = 0.0306. 18 weeks: * p = 0.0165. C Impaired spontaneous alternation performance in chst3 knockout mice. Unpaired two-tailed t -test, 4 M: ** p = 0.0011. 7 M: ** p = 0.001. D Atypical marble-burying behaviour in chst3 KO mice on ageing. Unpaired two-tailed t -test. 12 M: ** p < 0.01. In WT the ageing impaired marble-burying behaviour, 7 M vs 12 M *** p < 0.001. E Experimental timeline of AAVchst3 injection to chst3 KO mice at 4 M. F chst3 gene delivery recovered memory in 4 M chst3 KO mice line. Unpaired two-tailed t -test, 3 h delay: ** p < 0.01.CC-BY · From the PDF
Fig. 4 ARMI is prevented in animals overexpressing C6 sulfotransferase. Restoration of C6S restores LTP in brain slices. A Experimental timeline of AAV-chst3 injection to 5 M or 19 M C57BL/6 mice. B Age-mediated memory loss in C57bl/6 mice and SOR memory restoration by injection of AAV1Chst3 to PRh. Three hours memory retention: * p = 0.023. Six hours memory retention: ** p = 0.0071. In young mice (6 M), 24 h memory was enhanced after AAV-chst3 injection. * p = 0.0317. Data present as mean ± SEM. All data were analysed by unpaired two-tailed t -test. C In chst3 transgenic mice, age-mediated memory loss was absent. Age: 20 M, 6 h memory retention: WT vs Tg * p = 0.0361. Data present as mean ± SEM. D LTP in perirhinal cortex slices in chst3 KO mice. Left: LTP is signi fi cantly decreased (two-way RM ANOVA: * p = 0.018). Left inset: examples of fEPSP. Right: I/O curve of evoked fEPSP amplitude (two-way RM ANOVA, n.s. p = 0.758). E LTP is increased in CA3-CA1 in chst3 KO mice (two-way RM ANOVA, * p = 0.010). Left inset: Examples of fEPSP. Right: I/O curve (two-way RM ANOVA, n.s. p = 0.457). Graphs are mean±SEM. F LTP in perirhinal cortex in AAVchst3 injected aged mice. (a) Timeline. (b) LTP in the perirhinal cortex (two-way RM ANOVA: * p = 0.036). Left inset: examples of fEPSP. (c) I/O curve (two-way RM ANOVA, p > 0.05).
Fig. 4 ARMI is prevented in animals overexpressing C6 sulfotransferase. Restoration of C6S restores LTP in brain slices. A Experimental timeline of AAV-chst3 injection to 5 M or 19 M C57BL/6 mice. B Age-mediated memory loss in C57bl/6 mice and SOR memory restoration by injection of AAV1Chst3 to PRh. Three hours memory retention: * p = 0.023. Six hours memory retention: ** p = 0.0071. In young mice (6 M), 24 h memory was enhanced after AAV-chst3 injection. * p = 0.0317. Data present as mean ± SEM. All data were analysed by unpaired two-tailed t -test. C In chst3 transgenic mice, age-mediated memory loss was absent. Age: 20 M, 6 h memory retention: WT vs Tg * p = 0.0361. Data present as mean ± SEM. D LTP in perirhinal cortex slices in chst3 KO mice. Left: LTP is signi fi cantly decreased (two-way RM ANOVA: * p = 0.018). Left inset: examples of fEPSP. Right: I/O curve of evoked fEPSP amplitude (two-way RM ANOVA, n.s. p = 0.758). E LTP is increased in CA3-CA1 in chst3 KO mice (two-way RM ANOVA, * p = 0.010). Left inset: Examples of fEPSP. Right: I/O curve (two-way RM ANOVA, n.s. p = 0.457). Graphs are mean±SEM. F LTP in perirhinal cortex in AAVchst3 injected aged mice. (a) Timeline. (b) LTP in the perirhinal cortex (two-way RM ANOVA: * p = 0.036). Left inset: examples of fEPSP. (c) I/O curve (two-way RM ANOVA, p > 0.05).CC-BY · From the PDF
Image 12
CC-BY · From the PDF
Fig. 5 Restoration of C6S affects PV levels and inhibitory synapses. A PV and WFA network in AAVchst3 injected aged mice (a) PV network. High: *** p = 0.0001. Low: n.s. p = 0.079. (b) WFA network. High: *** p < 0.0001. Low: ** p = 0.0016. B (a), (b) chst3 increased the inhibitory synapses on PV neurons in aged mice. (a) n = 6/group. 6 M vs 20 M *** p = 0.0002. 20 M vs 20Mchst3 , * p = 0.01. Unpaired two-tailed t -test. (b) Staining pro fi les of gephyrin ( + ) synaptic puncta on PV cells. B (c) Correlation pro fi les between numbers of gephyrin synaptic puncta and PV intensity. 20 M: correlation * p = 0.0186, Spearman r = -0.3576, 20M-Chst3: Correlation *** p = 0.0003, Spearman r = -0.4717, 6 M: Correlation * p = 0.0364, Spearman r = -0.2686.
Fig. 5 Restoration of C6S affects PV levels and inhibitory synapses. A PV and WFA network in AAVchst3 injected aged mice (a) PV network. High: *** p = 0.0001. Low: n.s. p = 0.079. (b) WFA network. High: *** p < 0.0001. Low: ** p = 0.0016. B (a), (b) chst3 increased the inhibitory synapses on PV neurons in aged mice. (a) n = 6/group. 6 M vs 20 M *** p = 0.0002. 20 M vs 20Mchst3 , * p = 0.01. Unpaired two-tailed t -test. (b) Staining pro fi les of gephyrin ( + ) synaptic puncta on PV cells. B (c) Correlation pro fi les between numbers of gephyrin synaptic puncta and PV intensity. 20 M: correlation * p = 0.0186, Spearman r = -0.3576, 20M-Chst3: Correlation *** p = 0.0003, Spearman r = -0.4717, 6 M: Correlation * p = 0.0364, Spearman r = -0.2686.CC-BY · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

2 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 67 references

Cited by

See all 77

Metadata

Authors
Yang, S., Gigout, S., Molinaro, A., Naito-Matsui, Y., Hilton, S., Foscarin, S., Nieuwenhuis, B., Tan, C. L., Verhaagen, J., Pizzorusso, T., Saksida, L. M., Bussey, T. M., Kitagawa, H., Kwok, J. C. F., & Fawcett, J. W.
Affiliations
  • University of Cambridge (GB)
  • University of Leeds (GB)
  • Neuroscience Institute (IT)
  • Netherlands Institute for Neuroscience (NL)
  • National University Hospital (SG)
  • Western University (CA)
  • Kobe Pharmaceutical University (JP)
  • Czech Academy of Sciences (CZ)
Corresponding author
  • Yang, Sujeong
  • Kwok, Jessica C. F.
  • Fawcett, James W.
Venue
Molecular Psychiatry
Published
2021-07-16
Volume
26
Issue
10
Pages
5658-5668
ISSN
  • 1359-4184 (ISSN-L)
  • 1476-5578
OpenAlex
W3181340735
Cited by
70
References
67
Citations by year
2026: 7 · 2025: 15 · 2024: 17 · 2023: 12 · 2022: 15 · 2021: 4
FWCI
6.26
Type
journal article
Language
en
Open access
Licence
Locations
  • Molecular Psychiatry (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • KNAW Research Portal (The Royal Netherlands Academy of Arts and Sciences) (publishedVersion, other-oa)
  • White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
  • Cambridge University Engineering Department Publications Database (submittedVersion)
  • Scholarship@Western (Western University) (submittedVersion)
  • Scuola Normale Superiore di Pisa (submittedVersion, cc-by)
  • Apollo (University of Cambridge) (submittedVersion)
  • Apollo (University of Cambridge) (submittedVersion, cc-by)
  • Apollo
  • Apollo (cc-by)
Funders
  • Grantová Agentura České Republiky (CZ.02.1.01/0.0, CZ.02.1.01)
  • Medical Research Council (MC_PC_16050, G1000864, MR/S011110/1, MR/R004463/1, MR/V002694/1)
  • Japan Society for the Promotion of Science (20H03386, 19K06572)
  • FP7 Ideas: European Research Council (294502)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
Keywords
chondroitin-6-sulfate, perineuronal nets, neuroplasticity, memory, aging, CHST3, age-related memory impairment, long-term potentiation, proteoglycans, cognitive decline
MeSH terms
Aging, Animals, Brain, Chondroitin Sulfates, Extracellular Matrix, Neuronal Plasticity, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Chondroitin 6-sulphate is required for neuroplasticity and memory in ageing. https://app.cochat.ai/papers/10.1038/s41380-021-01208-9
The paper
Yang, S., Gigout, S., Molinaro, A., Naito-Matsui, Y., Hilton, S., Foscarin, S., Nieuwenhuis, B., Tan, C. L., Verhaagen, J., Pizzorusso, T., Saksida, L. M., Bussey, T. M., Kitagawa, H., Kwok, J. C. F., & Fawcett, J. W. (2021). Chondroitin 6-sulphate is required for neuroplasticity and memory in ageing. Molecular Psychiatry. https://doi.org/10.1038/s41380-021-01208-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.